Asher Mullard. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » Biphenyl Compounds/therapeutic useBone Density Conservation Agents/pharmacologyBone Density Conservation Agents/therapeutic useCathepsin K/antagonists & inhibitorsClinical Trials as TopicDrug Industry/trendsHumansOsteoporosis/diagnosisOsteoporosis/drug therapy
Substances: See more » Biphenyl CompoundsBone Density Conservation AgentsCTSK protein, humanCathepsin Kodanacatib
Year: 2016 PMID: 27681784 DOI: 10.1038/nrd.2016.207
Source DB: PubMed Journal: Nat Rev Drug Discov ISSN: 1474-1776 Impact factor: 84.694